-
公开(公告)号:US11033526B2
公开(公告)日:2021-06-15
申请号:US15559241
申请日:2016-03-17
发明人: Patricia Espinheira De Sá Maciel , Andreia Cristiana Teixeira De Castro , Ana Luísa De Jales Monteiro De Sousa , Ana Sofia Teixeira Esteves , Nuno Jorge Carvalho Sousa
IPC分类号: A61K31/343 , A61P25/28 , A61K9/00
摘要: Citalopram or escitalopram, pharmaceutically acceptable salts or derivatives thereof for use in the treatment of neurodegenerative diseases The disclosure subject matter is related to the use of citalopram or escitalopram, pharmaceutically acceptable salts or derivatives thereof, in the treatment of neurodegenerative diseases that are positively influenced by the decrease of protein misfolding and/or aggregation, in particular by oral administration.